Condition
Tufted Angioma
Total Trials
3
Recruiting
1
Active
1
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 55/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
200%
2 of 1 completed with results
Key Signals
2 with results50% success
Data Visualizations
Phase Distribution
3Total
P 2 (2)
P 4 (1)
Trial Status
Terminated1
Recruiting1
Completed1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT00975819Phase 2Completed
Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies
NCT04921722Phase 4Recruiting
Percutaneous Administration of Sirolimus in the Treatment of Superficial Complicated Vascular Anomalies
NCT02110069Phase 2Terminated
A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors
Showing all 3 trials